XOMA Royalty Payables and Accrued Expenses (Quarterly) Insights

XOMA Royalty Corp. (XOMA)

26.73 -0.19 (-0.71%) USD | NASDAQ | Jan 23, 16:00

26.73 0.00 (0.00%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for XOMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Mirum Pharmaceuticals, Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
Rezolute, Inc.	Upgrade
Vistagen Therapeutics, Inc.	Upgrade
Zevra Therapeutics, Inc.	Upgrade